What is he best known for?
The fields of study he is best known for:
His main research concerns Immunology, Transplantation, Haematopoiesis, Stem cell and Progenitor cell.
The various areas that he examines in his Immunology study include Cancer research and In vivo.
His Transplantation study integrates concerns from other disciplines, such as Platelet activation, Bone marrow and Haemophilia, Haemophilia A.
His Haematopoiesis study combines topics in areas such as Endothelial stem cell and Genetic enhancement.
His Progenitor cell research is multidisciplinary, incorporating perspectives in Genetic transfer and Cell division.
His work is dedicated to discovering how Viral vector, Cytotoxic T cell are connected with Virology and other disciplines.
His most cited work include:
- Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia (959 citations)
- Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods. (273 citations)
- Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells. (263 citations)
What are the main themes of his work throughout his whole career to date?
Kenneth Cornetta spends much of his time researching Genetic enhancement, Virology, Viral vector, Molecular biology and Immunology.
His studies in Genetic enhancement integrate themes in fields like Clinical trial and Severe combined immunodeficiency.
Kenneth Cornetta combines subjects such as Cell culture and Vector, Replication Competent Retrovirus with his study of Virology.
The Immunology study combines topics in areas such as Cancer, Haematopoiesis and Transplantation.
His Haematopoiesis research includes themes of Cancer research and Bone marrow.
As part of the same scientific family, Kenneth Cornetta usually focuses on Transplantation, concentrating on Stem cell and intersecting with Cord blood.
He most often published in these fields:
- Genetic enhancement (26.52%)
- Virology (24.86%)
- Viral vector (22.10%)
What were the highlights of his more recent work (between 2012-2021)?
- Genetic enhancement (26.52%)
- Viral vector (22.10%)
- Stem cell (17.13%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Genetic enhancement, Viral vector, Stem cell, Virology and Immunology.
He has researched Genetic enhancement in several fields, including Hematopoietic stem cell transplantation, Clinical trial and Severe combined immunodeficiency.
He has included themes like Haematopoiesis, T cell, Adoptive cell transfer, T-cell receptor and Immunotherapy in his Viral vector study.
The study incorporates disciplines such as Progenitor cell and Cancer research in addition to Haematopoiesis.
His research in Stem cell intersects with topics in Immune system, Transplantation and Suicide gene.
His Immunology study combines topics from a wide range of disciplines, such as Hemostasis, Coagulation, In vivo and Haemophilia A.
Between 2012 and 2021, his most popular works were:
- Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma (137 citations)
- In Vivo DPP-4 Inhibition to Enhance Engraftment of Single-Unit Cord Blood Transplants in Adults with Hematological Malignancies (88 citations)
- Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A (74 citations)
In his most recent research, the most cited papers focused on:
Kenneth Cornetta mainly investigates Genetic enhancement, Transplantation, Stem cell, Viral vector and Immunology.
The Genetic therapy research he does as part of his general Genetic enhancement study is frequently linked to other disciplines of science, such as Food and drug administration, therefore creating a link between diverse domains of science.
His study in Transplantation is interdisciplinary in nature, drawing from both Hemostasis, Umbilical cord and Coagulation.
His Stem cell research incorporates themes from Internal medicine and Severe combined immunodeficiency, Adenosine deaminase deficiency.
His Viral vector research incorporates elements of T cell, Virology and Immunotherapy.
His studies deal with areas such as Haemophilia and Haemophilia A as well as Immunology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
